Abeona Therapeutics

5 Cell and Gene Therapy Decisions to Watch in 2024
BioSpace
Mon, 04/22/24 - 11:38 am
cell therapy
gene therapy
Pfizer
Beqvez
hemophilia B
Abeona Therapeutics
pz-cel
recessive dystrophic epidermolysis bullosa
Rocket Pharmaceuticals
Kresladi
Leukocyte adhesion deficiency-1
Adaptimmune
afami-cel
advanced synovial sarcoma
Autolus Therapeutics
obe-cel
B cell acute lymphoblastic leukemia
Ultragenyx strikes deal with struggling Abeona for rare disease gene therapy
BioPharma Dive
Tue, 05/17/22 - 10:30 pm
Ultragenyx
Sanfillipo Syndrome
gene therapy
Abeona Therapeutics
Two Cell Therapy Companies Bag New CEOs
BioSpace
Tue, 03/23/21 - 10:35 am
cell therapy
Pharma CEOs
AlloVir
Abeona Therapeutics
FDA puts the brakes on a rare disease biotech’s PhIII as regulators wait for an update — shares crumble
Endpoints
Mon, 09/23/19 - 10:41 am
Abeona Therapeutics
clinical trials
EB-101
recessive dystrophic epidermolysis bullosa
FDA
3 Biotech Stocks That Soared This Week
Motley Fool
Sat, 04/14/18 - 12:37 pm
AveXis
Abeona Therapeutics
Spectrum Pharmaceuticals
Novartis
M&A
poziotinib
EB-101
Abeona Therapeutics Receives FDA Rare Pediatric Disease Designation for ABO-202 Gene Therapy Program in CLN1 Disease
CP Wire
Fri, 03/16/18 - 09:37 am
Abeona Therapeutics
FDA
pediatrics
ABO-202
Rare Pediatric Disease designation
priority review vouchers
3 Biotech Stocks That Skyrocketed This Past Week
Motley Fool
Mon, 09/4/17 - 10:07 am
Abeona Therapeutics
EB-101
Sangamo BioSciences
SB-525
Juno Therapeutics
CAR-T